Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Giant salamander skin mucus extract hydrolyzate refers to the enzymatically processed bioactive peptides and proteins derived from the skin mucus of the Chinese giant salamander (Andrias davidianus). This substance is obtained through specific enzymatic hydrolysis methods that break down larger proteins into smaller peptides. Research indicates that these extracts possess a range of biological activities, including photoprotective effects against UVA-induced damage in cells[4], wound healing properties[6], anti-inflammatory activity via modulation of lincRNA-EPS/NF-κB signaling pathways[2], and potential antitumor effects by inhibiting cell migration, arresting cell cycle progression, and inducing apoptosis in cancer cells[1]. The primary mechanisms are attributed to small molecular weight collagen-derived peptides rich in hydrophobic amino acids. These extracts are being explored for use as medicinal functional foods, cosmeceuticals (skin care), and possibly as medical adhesives or wound dressings due to their strong tissue-sealing properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on giant salamander skin mucus extract hydrolyzate.